Triflusal ( Triflusal, Disgren, Grendis, Aflen, Triflux )

产品货号. M14050 CAS No. 322-79-2

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Triflusal
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Triflusal能通过乙酰化COX-1，不可逆地抑制血小板中血栓素B2的产生。
产品描述

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
体外实验

——
体内实验

——
同义词

Triflusal, Disgren, Grendis, Aflen, Triflux
通路

Angiogenesis
靶点

PDE
受体

PDE| TXA2R
研究领域

Inflammation/Immunology
适应症

——

1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)

计算器

产品手册

关联产品

AGK2

AGK2（IC50=3.5 μM）是一种有效的、特异性的SIRT2抑制剂。
BRL 50481

BRL-50481 是一种新型选择性 PDE7 抑制剂，对 PDE7A、PDE7B、PDE4 和 PDE3 的 IC50 值分别为 0.15、12.1、62 和 490 μM。
Verofylline

Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.